| 2024-02 |
Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer |
Cancer Research
|
| 2024-02 |
Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer |
Cancer Research
|
| 2023-12 |
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer |
New England Journal of Medicine
|
| 2023-12 |
Initial experience with the da Vinci SP robot-assisted surgical staging of endometrial cancer: a retrospective comparison with conventional laparotomy |
Journal of Robotic Surgery
|
| 2023-12 |
Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer |
GLAND SURGERY
|
| 2023-12 |
Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045 |
International Journal of Cancer
|
| 2023-11 |
Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer |
Scientific Reports
|
| 2023-11 |
Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer |
British Journal of Cancer
|
| 2023-11 |
Comparison of Single-Port Laparoscopy with Other Surgical Approaches in Endometrial Cancer Surgical Staging: Propensity-Score-Matched Analysis |
Cancers
|
| 2023-11 |
Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy |
JAMA Surgery
|
| 2023-11 |
Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience |
Journal of Gynecologic Oncology
|
| 2023-10 |
Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: Primary analysis in the original cohort of KGOG3046/TRU-D |
Journal for ImmunoTherapy of Cancer
|
| 2023-10 |
Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC) |
BMC Cancer
|
| 2023-09 |
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4 |
Nature Communications
|
| 2023-08 |
Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer |
Journal of Obstetrics and Gynaecology Research
|
| 2023-07 |
Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With BRCA-Mutated Ovarian Cancer |
Clinical Cancer Research
|
| 2023-07 |
Comparing surgical outcomes of da Vinci SP and da Vinci Xi for endometrial cancer surgical staging in a propensity score-matched study |
Scientific Reports
|
| 2023-07 |
RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma |
Journal of Gynecologic Oncology
|
| 2023-06 |
Sentinel lymph node biopsy in endometrial cancer: The new norm - A multicentre, international experience |
Surgical Oncology
|
| 2023-05 |
Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer |
FRONTIERS IN ONCOLOGY
|
| 2023-05 |
CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy |
Clinical Cancer Research
|
| 2023-04 |
BNT162b2 접종과 면역관문억제제 치료 이후 발생한 이상 반응 1예 |
대한내과학회지
|
| 2023-03 |
Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3 |
Journal of Gynecologic Oncology
|
| 2023-03 |
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer |
Journal of Gynecologic Oncology
|
| 2022-11 |
A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer |
Gynecologic Oncology
|
| 2022-09 |
Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity? |
GYNECOLOGIC ONCOLOGY
|
| 2022-08 |
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup |
LANCET ONCOLOGY
|
| 2022-08 |
Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer |
Frontiers in Oncology
|
| 2022-07 |
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial |
Journal of Gynecologic Oncology
|
| 2022-07 |
A Phase II Trial to Evaluate the Efficacy of Bortezomib and Liposomal Doxorubicin in Patients With BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer (KGOG 3044/EBLIN) |
IN VIVO
|
| 2022-07 |
Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study |
Frontiers in Oncology
|
| 2022-07 |
Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test |
CANCERS
|
| 2022-05 |
Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: A multicenter study in Korea |
Gynecologic Oncology
|
| 2022-05 |
Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer |
Cancers
|
| 2022-05 |
Prognostic value of complete metabolic response on 18F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer |
JOURNAL OF GYNECOLOGIC ONCOLOGY
|
| 2022-05 |
PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies |
Journal of Gynecologic Oncology
|
| 2022-04 |
Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort study |
Gynecologic Oncology
|
| 2022-03 |
Major clinical research advances in gynecologic cancer in 2021 |
Journal of Gynecologic Oncology
|
| 2022-03 |
Indocyanine green fluorescent image-guided inguinal sentinel lymph node biopsy in vulvar cancer |
Obstetrics & Gynecology Science
|
| 2022-03 |
ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma |
CELL DEATH & DISEASE
|
| 2022-03 |
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial |
JOURNAL OF GYNECOLOGIC ONCOLOGY
|
| 2022-02 |
Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study |
Gynecologic Oncology
|
| 2022-01 |
Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response |
Cancer Research
|
| 2021-12 |
Comparison of Serum Anti-Mullerian Hormone-Level Changes in Single-Port Laparoscopic Endometriotic and Non-Endometriotic Ovarian Cyst Enucleations |
Journal of menopausal medicine 대한폐경학회지
|
| 2021-11 |
Cancer Patient Tissueoid with Self-Homing Nano-Targeting of Metabolic Inhibitor |
Advanced Science
|
| 2021-09 |
CT-Based Fagotti Scoring System for Non-Invasive Prediction of Cytoreduction Surgery Outcome in Patients with Advanced Ovarian Cancer |
KOREAN JOURNAL OF RADIOLOGY
|
| 2021-08 |
Impact of subcutaneous negative pressure drains on surgical wound healing in ovarian cancer |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
|
| 2021-05 |
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee |
GYNECOLOGIC ONCOLOGY
|
| 2021-04 |
Association between PD‑L1 expression and 18F‑FDG uptake in ovarian cancer |
ANNALS OF NUCLEAR MEDICINE
|
| 2021-04 |
Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer |
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
|
| 2021-03 |
A single-arm phase ii study of olaparib maintenance with pembrolizumab and bevacizumab in brca non-mutated patients with platinum-sensitive recurrent ovarian cancer (Opeb-01) |
JOURNAL OF GYNECOLOGIC ONCOLOGY
|
| 2021-03 |
Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix |
MODERN PATHOLOGY
|
| 2021-01 |
Comparison of single-port laparoscopy and laparotomy in early ovarian cancer surgical staging |
Obstetrics & Gynecology Science
|
| 2021-01 |
Time for enhancing government-led primary prevention of cervical cancer |
JOURNAL OF GYNECOLOGIC ONCOLOGY
|
| 2021-01 |
Effects of Korean Red Ginseng ( Panax ginseng C.A. Meyer) on Menopausal Symptoms in Premenopausal Women After Gynecologic Cancer Surgery: A Double-Blind, Randomized Controlled Trial |
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
|
| 2021-01 |
Impact of the Learning Curve on the Survival of Abdominal or Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer |
CANCER RESEARCH AND TREATMENT
|
| 2020-12 |
4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39+ CD8 T cells from primary and metastatic sites of epithelial ovarian cancers |
Journal for ImmunoTherapy of Cancer
|
| 2020-11 |
Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy |
EUROPEAN JOURNAL OF CANCER
|
| 2020-10 |
Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer |
CANCER RESEARCH AND TREATMENT
|
| 2020-09 |
Survival outcomes of single-port access laparoscopic radical hysterectomy for early-stage cervical cancer |
SURGICAL ONCOLOGY-OXFORD
|
| 2020-07 |
Recommendations for gynecologic cancer care during the COVID-19 pandemic |
JOURNAL OF GYNECOLOGIC ONCOLOGY
|
| 2020-06 |
Pelvic malakoplakia presenting as endometrial cancer: a case report |
Obstetrics & Gynecology Science
|
| 2020-05 |
Effect of bupivacaine versus lidocaine local anesthesia on postoperative pain reduction in single-port access laparoscopic adnexal surgery using propensity score matching |
Obstetrics & Gynecology Science
|
| 2020-05 |
Major clinical research advances in gynecologic cancer in 2019 |
JOURNAL OF GYNECOLOGIC ONCOLOGY
|
| 2020-04 |
A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer |
YONSEI MEDICAL JOURNAL
|
| 2020-04 |
Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy |
Journal of Clinical Medicine
|
| 2020-04 |
Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy |
INTERNATIONAL JOURNAL OF CANCER
|
| 2020-03 |
Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer |
BMC CANCER
|
| 2020-03 |
Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer |
JOURNAL OF GYNECOLOGIC ONCOLOGY
|
| 2020-03 |
Comparison of Outcomes Between the One-Step and Two-Step Sentinel Lymph Node Mapping Techniques in Endometrial Cancer |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
|
| 2020-03 |
Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer. |
BMC CANCER
|
| 2020-03 |
4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma |
HEPATOLOGY
|
| 2020-02 |
Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter study |
Journal of Obstetrics and Gynaecology Research
|
| 2020-02 |
The institutional learning curve is associated with survival outcomes of robotic radical hysterectomy for early-stage cervical cancer-a retrospective study. |
BMC CANCER
|
| 2019-12 |
Patterns of initially overlooked recurrence of peritoneal lesions in patients with advanced ovarian cancer on postoperative multi-detector row CT |
ACTA RADIOLOGICA
|
| 2019-11 |
Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study |
Journal of Clinical Medicine
|
| 2019-11 |
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer |
Gynecologic Oncology
|
| 2019-11 |
A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D |
JOURNAL OF GYNECOLOGIC ONCOLOGY
|